Experience with an extended-release opioid formulation designed to reduce abuse liability in a community-based pain management clinic

References

• ChouRFanciulloGJFinePGOpioid treatment guidelines. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer painJ Pain200910211313019187889
   PubMed Web of Science ®Google Scholar
• GallagherRMRosenthalLJChronic pain and opiates: balancing pain control and risks in long-term opioid treatmentArch Phys Med Rehabil2008893 Suppl 1S77S8218295655
   PubMed Web of Science ®Google Scholar
• McCarbergBStanosSKey patient assessment tools and treatment strategies for pain managementPain Pract20088642343219000171
   PubMedGoogle Scholar
• KuehnBMOpioid prescriptions soar: increase in legitimate use as well as abuseJAMA2007297324925117227967
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration (SAMHSA)Results from the 2009 National Survey on Drug Use and Health: Volume 1. Summary of National FindingsRockville, MDSAMHSA2010
   Google Scholar
• IvesTJChelminskiPRHammett-StablerCAPredictors of opioid misuse in patients with chronic pain: a prospective cohort studyBMC Health Serv Res200664616595013
   PubMed Web of Science ®Google Scholar
• FlemingMFBalousekSLKlessigCLMundtMPBrownDDSubstance use disorders in a primary care sample receiving daily opioid therapyJ Pain20078757358217499555
   PubMed Web of Science ®Google Scholar
• SullivanMDEdlundMJFanMYRisks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP StudyPain2010150233233920554392
   PubMed Web of Science ®Google Scholar
• PassikSDMessinaJGolsorkhiJXieFAberrant drug-related behavior observed during clinical studies involving patients taking chronic opioid therapy for persistent pain and fentanyl buccal tablet for breakthrough painJ Pain Symptom Manage2010 [Epub ahead of print.]
   Web of Science ®Google Scholar
• Federation of State Medical Boards of the United States IncModel Policy for the use of controlled substances for the treatment of pain52004 Available from: http://www.fsmb.org/pdf.2004_grpol_controlled_substances.pdfAccessed December 21, 2010
   Google Scholar
• GourlayDLHeitHAAlmahreziAUniversal precautions in pain medicine: a rational approach to the treatment of chronic painPain Med20056210711215773874
   PubMed Web of Science ®Google Scholar
• GourlayDLHeitHAUniversal precautions revisited: managing the inherited pain patientPain Med200910Suppl 2S115S12319691682
   PubMed Web of Science ®Google Scholar
• BrennanMJStanosSStrategies to optimize pain management with opioids while minimizing risk of abusePM R20102654455820630441
   PubMedGoogle Scholar
• PassikSDIssues in long-term opioid therapy: unmet needs, risks, and solutionsMayo Clin Proc200984759360119567713
   PubMed Web of Science ®Google Scholar
• Embeda [package insert]Bristol, TNKing Pharmaceuticals®, Inc.62009
   Google Scholar
• StaufferJSetnikBSokolowskaMSubjective effects and safety of whole and tampered morphine sulfate and naltrexone hydrochloride (ALO-01) extended-release capsules versus morphine solution and placebo in experienced non-dependent opioid users: a randomized, double-blind, placebo-controlled, crossover studyClin Drug Investig20092912777790
   PubMed Web of Science ®Google Scholar
• KatzNSunSJohnsonFStaufferJALO-01 (morphine sulfate and naltrexone hydrochloride) extended release capsules in the treatment of chronic pain of osteoarthritis of the hip or knee: pharmacokinetics, efficacy, and safetyJ Pain201011430331119944650
   PubMed Web of Science ®Google Scholar
• JohnsonFKStarkJGBieberdorfFAStaufferJRelative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: a single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteersClin Ther20103261149116420637968
   PubMed Web of Science ®Google Scholar
• WebsterLRJohnsonFKStaufferJSetnikBCiricSImpact of intravenous naltrexone on intravenous morphine-induced high, drug liking, and euphoric effects in experienced non-dependent male opioid usersDrugs R and D2011 [Epub ahead of print]
   Google Scholar
• JangDHRobeJCHoffmanRSSevere opioid withdrawal due to misuse of new combined morphine and naltrexone product (Embeda)Ann Emerg Med201055330330420171465
   PubMed Web of Science ®Google Scholar
• RuanXChenTGudinJCouchJPChiravuriSAcute opioid withdrawal precipitated by ingestion of crushed Embeda (morphine extended release with sequestered naltrexone): case report and the focused review of the literatureJ Opioid Manag20106430030320862910
   PubMedGoogle Scholar
• Oxycontin [package insert]Stamford, CTPurdue Pharma L.P.42010
   Google Scholar
• OxyIR [package insert]Stamford, CTPurdue Pharma, L.P.22007
   Google Scholar
• PassikSDKirshKLWhitcombLA new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapyClin Ther200426455256115189752
   PubMed Web of Science ®Google Scholar
• Percocet [package insert]Chadds Ford, PAEndo Pharmaceuticals, Inc112006
   Google Scholar
• Soma [package insert]Somerset, NJMeda Pharmaceuticals, Inc102009
   Google Scholar
• ColamecoSCorenJSOpioid induced endocrinopathyJ Am Osteopath Assoc20091091202519193821
   PubMedGoogle Scholar
• RhodinAStridsbergMGordhTOpioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatmentClin J Pain201026537438020473043
   PubMed Web of Science ®Google Scholar
• KatzNPAdamsEHChilcoatHChallenges in the development of prescription opioid abuse-deterrent formulationsClin J Pain200723864866017885342
   PubMed Web of Science ®Google Scholar
• American Academy of Pain Medicine, American Pain Society, American Society of Addiction MedicineDefinitions related to the use of opioids for the treatment of pain: a consensus statement for the American Academy of Pain, the American Pain Society, and the American Society of Addiction Medicine2001 Available from: http://www.ampainsoc.org/advocacy/opioids2.htmAccessed December 21, 2010
   Google Scholar
• American Academy of Pain ManagementOpioid agreements/contracts: The American Academy of Pain Management’s take on the subject2010 Available from: http://www.aapainmanage.org/literature/Articles/OpioidAgreements.pdfAccessed December 21, 2010
   Google Scholar
• BirnbaumHGWhiteAGReynoldsJLEstimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspectiveClin J Pain200622866767616988561
   PubMed Web of Science ®Google Scholar
• Incidence and prevalence of ESRDAm J Kidney Dis1999342 Suppl 1S40S50
   Google Scholar
• KnotkovaHFinePGPortenoyRKOpioid rotation: the science and the limitations of the equianalgesic dose tableJ Pain Symptom Manage200938342643919735903
   PubMed Web of Science ®Google Scholar
• MercadanteSBrueraEOpioid switching: a systematic and critical reviewCancer Treat Rev200632430431516624490
   PubMed Web of Science ®Google Scholar
• KADIAN (morphine sulfate extended-release) Capsules [package insert]Morristown, NJActavis Kadian LLC22010
   Google Scholar
• WhiteAGBirnbaumHGMarevaMNDirect costs of opioid abuse in an insured population in the United StatesJ Manag Care Pharm200511646947915998164
   PubMedGoogle Scholar
• WhiteAGBirnbaumHGRothmanDBKatzNDevelopment of a budget-impact model to quantify potential cost savings from prescription opioids designed to deter abuse or ease of extractionAppl Health Econ Health Policy200971617019558195
   PubMedGoogle Scholar